Research
Hormonal
Hedonic feeding is driven by the mesolimbic dopaminergic system (specifically 'wanting'), which can override homeostatic satiety signals.
Your brain is wired to seek pleasure from palatable food via dopamine release, which can override signals of fullness. This is an evolutionary adaptation, not a moral failing. Understanding that 'wanting' (motivation) is distinct from 'liking' (pleasure) helps explain why you might crave food even when not hungry.
StrongSupportsVERY_HIGH confidence
It is increasingly recognized that much of the excess caloric intake in obesity is driven by pleasure or the rewarding properties of readily available palatable food.
Why this rating
Supported by extensive neurobiological literature cited (animal studies, genetic markers, neuroimaging).
Source
Neurobehavioral Inhibition of Reward‐driven Feeding: Implications for Dieting and Obesity
Bradley M. Appelhans · Obesity · 2009
DOI 10.1038/oby.2008.638
narrative_reviewCited 270×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →